4.7 Review

Review of Transient Receptor Potential Canonical (TRPC5) Channel Modulators and Diseases

Journal

JOURNAL OF MEDICINAL CHEMISTRY
Volume 62, Issue 17, Pages 7589-7602

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.8b01954

Keywords

-

Funding

  1. NIH (NIDDK) [R01DK103658]

Ask authors/readers for more resources

Transient receptor potential canonical (TRPC) channels are highly homologous, nonselective cation channels that form many homo- and heterotetrameric channels. These channels are highly abundant in the brain and kidney and have been implicated in numerous diseases, such as depression, addiction, and chronic kidney disease, among others. Historically, there have been very few selective modulators of the TRPC family in order to fully understand their role in disease despite their physiological significance. However, that has changed recently and there has been a significant increase in interest in this family of channels which has led to the emergence of selective tool compounds, and even preclinical drug candidates, over the past few years. This review will cover these new advancements in the discovery of TRPC modulators and the emergence of newly reported structural information which will undoubtedly lead to even greater advancements.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Pharmacology & Pharmacy

Nobiletin as a Molecule for Formulation Development: An Overview of Advanced Formulation and Nanotechnology-Based Strategies of Nobiletin

Siddharth S. Kesharwani, Pooja Mallya, Vadikari Arun Kumar, Vikas Jain, Swagat Sharma, Surajit Dey

AAPS PHARMSCITECH (2020)

Article Biochemistry & Molecular Biology

KVA-D-88, a Novel Preferable Phosphodiesterase 4B Inhibitor, Decreases Cocaine-Mediated Reward Properties in Vivo

Maria E. Burkovetskaya, Qiaoling Liu, Anish K. Vadukoot, Nagsen Gautam, Yazen Alnouti, Sushil Kumar, Klaus Miczek, Shilpa Buch, Corey R. Hopkins, Minglei Guo

ACS CHEMICAL NEUROSCIENCE (2020)

Article Chemistry, Medicinal

Discovery, synthesis and characterization of a series of 7-aryl-imidazo[1,2-a] pyridine-3-ylquinolines as activin-like kinase (ALK) inhibitors

Darren W. Engers, Sean R. Bollinger, Andrew S. Felts, Anish K. Vadukoot, Charles H. Williams, Anna L. Blobaum, Craig W. Lindsley, Charles C. Hong, Corey R. Hopkins

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)

Article Chemistry, Medicinal

Further SAR on the (Phenylsulfonyl)piperazine Scaffold as Inhibitors of the Aedes aegypti Kir1 (AeKir) Channel and Larvicides

Christopher D. Aretz, Sujay V. Kharade, Keagan Chronister, Renata Rusconi Trigueros, Erick J. Martinez Rodriguez, Peter M. Piermarini, Jerod S. Denton, Corey R. Hopkins

Summary: Zika virus, dengue fever, and chikungunya are arboviruses spread by infected Aedes aegypti mosquitoes. Current control strategies rely on using insecticides to prevent mosquito bites, but increasing resistance complicates control efforts. Inhibiting the Kir channel of Aedes aegypti has shown promise for developing novel mosquitocides.

CHEMMEDCHEM (2021)

Article Oncology

PIK3C3 Inhibition Promotes Sensitivity to Colon Cancer Therapy by Inhibiting Cancer Stem Cells

Balawant Kumar, Rizwan Ahmad, Swagat Sharma, Saiprasad Gowrikumar, Mark Primeaux, Sandeep Rana, Amarnath Natarajan, David Oupicky, Corey R. Hopkins, Punita Dhawan, Amar B. Singh

Summary: Colorectal cancer (CRC) therapy faces challenges due to cancer stem cells (CSCs) resistance to chemotherapy. Inhibiting autophagy with 36-077, a potent PIK3C3/VPS34 inhibitor, shows promise in improving the efficacy of CRC therapy by targeting CSCs.

CANCERS (2021)

Article Biochemistry & Molecular Biology

Virtual screening and biological evaluation of PPAR gamma antagonists as potential anti-prostate cancer agents

Suliman Almahmoud, Catherine C. Elix, Jeremy O. Jones, Corey R. Hopkins, Jonathan L. Vennerstrom, Haizhen A. Zhong

Summary: The PPAR gamma antagonist is crucial for inhibiting prostate cancer cell growth, and residues Arg288, Lys367, and His449 are important for PPAR gamma antagonist binding.

BIOORGANIC & MEDICINAL CHEMISTRY (2021)

Review Chemistry, Medicinal

Novel inhibitors of the renal inward rectifier potassium (Kir) channel of the mosquito vector Aedes aegypti

Viktoriya Mashinson, Corey R Hopkins

Summary: Mosquitoes remain the most lethal animals to humans due to the diseases they carry, but resistance to commonly used neurotoxic insecticides has emerged, impacting the efficacy of chemical control agents and beneficial insects such as honeybees. Developing new mosquitocides with novel mechanisms of action is urgently needed, and this review discusses efforts targeting the renal inward rectifier potassium channel (Kir) of mosquitoes in this regard.

FUTURE MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

Further Exploration of the Benzimidazole Scaffold as TRPC5 Inhibitors: Identification of 1-Alkyl-2-(pyrrolidin-1-yl)-1H-benzo[d]imidazoles as Potent and Selective Inhibitors

Swagat Sharma, Juan L. Pablo, Kirsten T. Tolentino, Wacey Gallegos, Jennifer Hinman, Madison Beninato, MacKenzie Asche, Anna Greka, Corey R. Hopkins

Summary: The transient receptor potential cation channel 5 (TRPC5) is a crucial player in various cellular processes and has gained attention as a potential therapeutic target. Recent studies highlight its involvement in regulating podocyte survival, suggesting a potential treatment for chronic kidney disease, while inhibition of TRPC5 is proposed as an effective approach for alleviating spontaneous and tactile pain. This report presents the discovery of 16 f as a potent and selective TRPC5 inhibitor through further exploration of the 2-aminobenzimidazole scaffold.

CHEMMEDCHEM (2022)

Article Chemistry, Medicinal

Synthesis and Biological Characterization of a Series of 2-Sulfonamidebenzamides as Allosteric Modulators of MrgX1

Swagat Sharma, Qi Peng, Anish K. Vadukoot, Christopher D. Aretz, Aaron A. Jensen, Alexander Wallick, Xinzhong Dong, Corey R. Hopkins

Summary: This study describes the discovery and characterization of a series of 2-sulfonamidebenzamides as allosteric modulators of MrgX1, a potential nonopioid receptor for chronic pain treatment. The research successfully improved the potency of MrgX1 and identified key compounds with improved stability.

ACS MEDICINAL CHEMISTRY LETTERS (2022)

Article Chemistry, Medicinal

Structure-Activity Relationships for the N-Me- Versus N-H-Amide Modification to Macrocyclic ent-Verticilide Antiarrhythmics

Abigail N. Smith, Madelaine P. Thorpe, Daniel J. Blackwell, Suzanne M. Batiste, Corey R. Hopkins, Nathan D. Schley, Bjorn C. Knollmann, Jeffrey N. Johnston

Summary: The synthesis of N-Me and N-H analogues of ent-verticilide was described to enable a structure-activity relationship study based on cardiac ryanodine receptor (RyR2) calcium ion channel inhibition. The study found that a high degree of N-methyl amide content is critical for activity in the ent-verticilide series but not entirely so for the ent-verticilide B1 series.

ACS MEDICINAL CHEMISTRY LETTERS (2022)

Article Biochemistry & Molecular Biology

Discovery, synthesis and biological evaluation of a series of N-(phenylcarbamothioyl)-2-napthamides as inhibitors of Claudin-1

Viktoriya Mashinson, Thomas M. Webster, Anish K. Vadukoot, Kirsten T. Tolentino, Princess Simeon, Iram Fatima, Punita Dhawan, Corey R. Hopkins

Summary: Colorectal cancer is a major cause of cancer-related deaths worldwide, and metastasis is a significant challenge in its treatment. The overexpression of claudin-1 in colorectal cancer is associated with poor prognosis, and inhibiting claudin-1 may have therapeutic potential. In this study, researchers identified a small molecule that inhibits claudin-1 dependent colorectal cancer progression and discovered a new compound with enhanced potency in SW620 cells through lead optimization efforts.

BIOORGANIC & MEDICINAL CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Discovery, synthesis and biological characterization of a series of N-(1-(1,1-dioxidotetrahydrothiophen-3-yl)-3-methyl-1H-pyrazol-5-yl)acetamide ethers as novel GIRK1/2 potassium channel activators

Swagat Sharma, Lauren Lesiak, Christopher D. Aretz, Yu Du, Sushil Kumar, Nagsen Gautam, Yazen Alnouti, Nikilesh Dhuria, Yashpal S. Chhonker, C. David Weaver, Corey R. Hopkins

Summary: The study describes the discovery and characterization of a series of N-(1-(1,1-dioxidotetrahydrothiophen-3-yl)-3-methyl-1H-pyrazol-5-yl)acetamide ethers as GIRK channel activators. These compounds show potent and selective activation of GIRK1/2 with improved metabolic stability compared to urea-based compounds.

RSC MEDICINAL CHEMISTRY (2021)

No Data Available